Different regulation in MS, with about half of Member States (MS) reporting that they consider at least some NCP as medicinal products by function.
Liikmesriigiti erinevalt reguleeritud, peaaegu pooled riigid käsitavad mõnda nikotiinisisaldusega toodet ravimina selle toime põhjal.